EIF4G2
Basic information
Region (hg38): 11:10797050-10808940
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 20.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_001418.4 | NP_001409.3 | 21 | yes | - |
ENST00000339995.11 | ENSP00000340281.6 | 21 | yes | - |
NM_001042559.3 | NP_001036024.3 | 20 | - | - |
NM_001172705.1 | NP_001166176.1 | 21 | - | - |
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (71 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EIF4G2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001418.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 2 | 1 | 6 | ||
| missense | 73 | 1 | 74 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 0 | 80 | 3 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| EIF4G2 | protein_coding | protein_coding | ENST00000526148 | 21 | 12061 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125721 | 0 | 3 | 125724 | 0.0000119 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.98 | 304 | 490 | 0.621 | 0.0000254 | 6011 |
| Missense in Polyphen | 80 | 212.32 | 0.37679 | 2727 | ||
| Synonymous | -0.276 | 176 | 171 | 1.03 | 0.00000917 | 1668 |
| Loss of Function | 6.79 | 1 | 55.6 | 0.0180 | 0.00000330 | 608 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000615 | 0.0000615 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.00 | 0.00 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Appears to play a role in the switch from cap-dependent to IRES-mediated translation during mitosis, apoptosis and viral infection. Cleaved by some caspases and viral proteases. {ECO:0000269|PubMed:11511540, ECO:0000269|PubMed:11943866, ECO:0000269|PubMed:9032289, ECO:0000269|PubMed:9049310}.;
- Pathway
- Viral myocarditis - Homo sapiens (human);RNA transport - Homo sapiens (human);Exercise-induced Circadian Regulation;internal ribosome entry pathway;Cytokine Signaling in Immune system;Immune System;eukaryotic protein translation;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- rvis_EVS
- -1.09
- rvis_percentile_EVS
- 7.11
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.967
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- translational initiation;regulation of translational initiation;cell cycle arrest;cell death;negative regulation of autophagy;positive regulation of cell growth;cellular macromolecule biosynthetic process
- Cellular component
- cytosol;cell-cell adherens junction;membrane;eukaryotic translation initiation factor 4F complex
- Molecular function
- RNA binding;mRNA binding;translation initiation factor activity;protein binding;translation factor activity, RNA binding;cadherin binding